"
Team:KU Leuven/Sponsors
From 2013.igem.org
(Difference between revisions)
| Line 136: | Line 136: | ||
<br/><br/> | <br/><br/> | ||
| - | <!-- | + | <!-- Thrombogenics --> |
| Line 156: | Line 156: | ||
</div> | </div> | ||
<div align="justify"> | <div align="justify"> | ||
| - | <span> ThromboGenics is dedicated to developing and commercializing new pharmacologic treatments that address important unmet clinical needs in ophthalmology and oncology. By achieving this goal ThromboGenics intends to assist clinicians around the world to continually improve treatment for patients with sight threatening ophthalmic disorders and cancer | + | <span> ThromboGenics is dedicated to developing and commercializing new pharmacologic treatments that address important unmet clinical needs in ophthalmology and oncology. By achieving this goal ThromboGenics intends to assist clinicians around the world to continually improve treatment for patients with sight threatening ophthalmic disorders and cancer.<span> |
</div> | </div> | ||
</td> | </td> | ||
| Line 174: | Line 174: | ||
<div align="right"> | <div align="right"> | ||
<a = href="http://www.eurogentec.com/eu-home.html" target="_blank"> | <a = href="http://www.eurogentec.com/eu-home.html" target="_blank"> | ||
| - | <span class="name"> | + | <span class="name">Eurogentec</span> |
</a> | </a> | ||
</div> | </div> | ||
| Line 194: | Line 194: | ||
<br/><br/> | <br/><br/> | ||
| + | <!-- BioSCENTer --> | ||
| + | |||
| + | |||
| + | <div align="left"> | ||
| + | <table border="0"> | ||
| + | <tr> | ||
| + | <td> | ||
| + | <a = href="http://www.kuleuven.be/bioscenter/" target="_blank"> | ||
| + | <img src="https://static.igem.org/mediawiki/2013/2/2c/Logo_BioSCENTer.png" width="150"> | ||
| + | </a> | ||
| + | </td> | ||
| + | <td width="15"> | ||
| + | </td> | ||
| + | <td width="500"> | ||
| + | <div align="left"> | ||
| + | <a = href="http://www.kuleuven.be/bioscenter/" target="_blank"> | ||
| + | <span class="name">BioSCENTer</span> | ||
| + | </a> | ||
| + | </div> | ||
| + | <div align="justify"> | ||
| + | <span> The Leuven Centre for Bio-Science, Bio-Engineering and Bio-Technology (BioSCENTer) is one of the largest research centres of the Group Science, Engineering and Technology of KU Leuven. It emerged in 2008 when four different research clusters: bioinformatics and systems biology, virtual life, Biomolecular interaction (Biomint), and evolutionary biology (iCEB) decided to join their efforts. Its aim is to integrate the available expertise on fundamental and applied Life Sciences; to stimulate cross-disciplinary fertilization; to boost excellence in research, teaching and training; to create an inspiring environment for innovative ideas on scientific and societal challenges; and to advise decision makers in policy and strategic initiatives.<span> | ||
| + | </div> | ||
| + | </td> | ||
| + | </tr> | ||
| + | </table> | ||
| + | </div> | ||
| + | |||
| + | <br/><br/> | ||
</html> | </html> | ||
Revision as of 12:08, 12 July 2013
Secret garden
Congratulations! You've found our secret garden! Follow the instructions below and win a great prize at the World jamboree!
- A video shows that two of our team members are having great fun at our favourite company. Do you know the name of the second member that appears in the video?
- For one of our models we had to do very extensive computations. To prevent our own computers from overheating and to keep the temperature in our iGEM room at a normal level, we used a supercomputer. Which centre maintains this supercomputer? (Dutch abbreviation)
- We organised a symposium with a debate, some seminars and 2 iGEM project presentations. An iGEM team came all the way from the Netherlands to present their project. What is the name of their city?
Now put all of these in this URL:https://2013.igem.org/Team:KU_Leuven/(firstname)(abbreviation)(city), (loose the brackets and put everything in lowercase) and follow the very last instruction to get your special jamboree prize!
|
Founded in 2004, BIOKÉ is a young and dynamic company that specializes in life sciences applications. They provide innovative, high-performance applications for genomics, proteomics and molecular diagnostics. With their technologies and equipment, they help accelerate and improve your diagnostics and research activities by enabling reproducible results.
|
|
Machery-Nagel, originated in Germany, offer since 1911 superior DNA, RNA and protein extraction kits. Kits are based on state-of-the art silica and anion-exchange technology, as well as magnetic beads and filtration approaches. Filter Service distributes these extraction and clean-up kits exclusively in Belgium as well as a great number of other consumables.
|
|
|
KU Leuven Research & Development (LRD) was established in 1972 as one of the first technology transfer offices in Europe. Over the last 40 years, LRD has developed a tradition of collaborating with industry, securing and licensing intellectual property rights, and creating spin-off companies. LRD is dedicated to building bridges between science and industry, and to transferring knowledge and technologies to the marketplace.
|
|
iMinds is an independent research institute, founded by the Flemish government in 2004, to stimulate innovation in the field of ICT.
The institute conducts both strategic and applied research, bringing together new technologies, societal challenges and questions from the business world in interdisciplinary research projects.
iMinds Future Health Department is located at the KU Leuven and focuses on innovative ICT solutions in healthcare. Its expertise comprises among others data analytics, bioinformatics, biomedical signal processing, advanced image computing, e-learing, serious gaming and user research.
|
|
|
ThromboGenics is dedicated to developing and commercializing new pharmacologic treatments that address important unmet clinical needs in ophthalmology and oncology. By achieving this goal ThromboGenics intends to assist clinicians around the world to continually improve treatment for patients with sight threatening ophthalmic disorders and cancer.
|
|
Eurogentec was founded in 1985 as a spin-off from the University of Liège. Eurogentec is a leading worldwide provider of reliable and innovative products and services to scientists in Life Science Research, Molecular Diagnostic and Therapeutic development and commercialisation.
|
|
|
The Leuven Centre for Bio-Science, Bio-Engineering and Bio-Technology (BioSCENTer) is one of the largest research centres of the Group Science, Engineering and Technology of KU Leuven. It emerged in 2008 when four different research clusters: bioinformatics and systems biology, virtual life, Biomolecular interaction (Biomint), and evolutionary biology (iCEB) decided to join their efforts. Its aim is to integrate the available expertise on fundamental and applied Life Sciences; to stimulate cross-disciplinary fertilization; to boost excellence in research, teaching and training; to create an inspiring environment for innovative ideas on scientific and societal challenges; and to advise decision makers in policy and strategic initiatives.
|
